Protagenic Therapeutics, Inc.
PTIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,838 | $1,288 | $215 | $541 |
| Short-Term Investments | $0 | $2,768 | $7,764 | $9,830 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $1,883 | $4,200 | $8,036 | $11,060 |
| Property Plant & Equip (Net) | $73 | $123 | $2 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $73 | $123 | $2 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,956 | $4,323 | $8,037 | $11,060 |
| Liabilities | – | – | – | – |
| Payables | $103 | $114 | $155 | $279 |
| Short-Term Debt | $0 | $0 | $344 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $943 | $655 | $1,120 | $800 |
| LT Debt | $0 | $0 | $0 | $318 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $318 |
| Other Liabilities | $0 | $0 | -$1,014 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $943 | $655 | $1,120 | $1,118 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $0 | $0 | $2 |
| Retained Earnings | -$36,303 | -$30,778 | -$25,777 | -$22,222 |
| AOCI | -$130 | -$114 | -$677 | -$248 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $1,013 | $3,668 | $6,918 | $9,942 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,956 | $4,323 | $8,037 | $11,060 |
| Net Debt | -$1,838 | -$1,288 | $129 | -$223 |